$3.9 M

MPME Mkt cap, 29-Jun-2017
Medisun Precision Medicine Net income (Q2, 2017)-3 M
Medisun Precision Medicine EBIT (Q2, 2017)-651.9 K
Medisun Precision Medicine Cash, 30-Jun-20174.6 K

Medisun Precision Medicine Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

818.1k555.5k1.8m1.3m

Prepaid Expenses

786.7k2.1m

Current Assets

818.1k555.5k2.0m1.3m

PP&E

166.1k

Total Assets

912.3k1.5m4.2m2.7m

Accounts Payable

209.7k266.0k180.8k

Current Liabilities

209.7k266.0k180.8k538.6k

Total Liabilities

559.7k619.1k564.8k538.6k

Common Stock

316.0579.0751.0

Preferred Stock

Additional Paid-in Capital

1.2m6.4m12.6m14.2m

Retained Earnings

(809.6k)(5.5m)(10.1m)(12.0m)

Total Equity

352.6k880.4k3.7m2.2m

Financial Leverage

2.6 x1.7 x1.2 x1.2 x

Medisun Precision Medicine Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(770.7k)(4.7m)(2.6m)(1.9m)

Depreciation and Amortization

107.8k94.3k42.3k118.0k

Accounts Payable

146.6k58.3k(85.2k)(141.0k)

Cash From Operating Activities

(513.7k)(163.7k)(486.2k)(675.0k)

Cash From Investing Activities

(2.6k)(162.3k)(251.0k)200.0k

Cash From Financing Activities

386.0k63.5k2.0m

Net Change in Cash

(130.4k)(262.6k)1.3m(474.9k)

Interest Paid

35.0k

Medisun Precision Medicine Ratios

USDY, 2017

Financial Leverage

1 x